Published in J Am Soc Nephrol on July 01, 1991
Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS One (2010) 1.13
Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism. World J Surg (2007) 0.96
Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis. Stem Cells (2013) 0.88
The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients. BMC Nephrol (2011) 0.86
Relationship between serum brain natriuretic peptide and heart function in patients with chronic kidney disease. Korean J Intern Med (2008) 0.85
Bioimpedance and echocardiography used interchangeably in volume comparison of dialysis patients. Hippokratia (2012) 0.83
Secondary hyperparathyroidism and target organs in chronic kidney disease. Hippokratia (2011) 0.80
Bone marrow cell therapies for endothelial repair and their relevance to kidney disease. Semin Nephrol (2012) 0.78
The Relationship Between Hemodialysis and the Echocardiographic Findings in Patients with Chronic Kidney Disease. Med Arch (2016) 0.75
Left ventricular morphology and diastolic function in uraemia: echocardiographic evidence of a specific cardiomyopathy. Br Heart J (1995) 0.75
The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med (1989) 4.41
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int (1995) 3.70
Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int (1998) 3.09
The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis (1996) 2.75
Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int (1989) 2.55
Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant (1996) 2.21
Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int (1995) 2.06
The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol (1995) 2.00
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int (1996) 1.99
Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol (1996) 1.64
Predicting glomerular function from adjusted serum creatinine. Nephron (1992) 1.64
Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol (2000) 1.52
Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int (1996) 1.46
The importance of renal impairment in the natural history of Bardet-Biedl syndrome. Am J Kidney Dis (1996) 1.30
Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis (1993) 1.28
Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol (1994) 1.16
The Kidney Disease Questionnaire: a test for measuring patient knowledge about end-stage renal disease. J Clin Epidemiol (1990) 1.05
Impact of renal transplantation on uremic cardiomyopathy. Transplantation (1995) 1.04
Clinical practice guidelines for vascular access. Canadian Society pf Nephrology. J Am Soc Nephrol (1999) 1.01
Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol (1998) 0.98
Cardiac disease in diabetic end-stage renal disease. Diabetologia (1997) 0.93
Development of a health questionnaire specific for end-stage renal disease. Nephron (1989) 0.88
Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine (Baltimore) (1991) 0.87
Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol (1996) 0.87
Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies. Transplantation (1987) 0.86
The clinical course of left ventricular hypertrophy in dialysis patients. Nephron (1990) 0.86
Recurrent hemoperitoneum in women receiving continuous ambulatory peritoneal dialysis. Ann Intern Med (1987) 0.81
The feasibility and efficacy of early discharge planning initiated by the admitting department in two acute care hospitals. Clin Invest Med (1994) 0.81
Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients. Am J Nephrol (1990) 0.80
Symptoms in end-stage renal disease: dialysis v transplantation. Transplant Proc (1987) 0.79
Low-output left ventricular failure in end-stage renal disease. Am J Nephrol (1987) 0.78
Cardiac disease in chronic uremia. Pathophysiology and clinical epidemiology. ASAIO J (1994) 0.77
Erythromycin-cyclosporine interaction in renal transplant recipients. Transplantation (1987) 0.77
Effect of interleukin-1beta on transforming growth factor-beta and bone morphogenetic protein-2 expression in human periodontal ligament and alveolar bone cells in culture: modulation by avocado and soybean unsaponifiables. J Periodontol (2006) 0.77
Congestive heart failure in dialysis patients. Arch Intern Med (1988) 0.76
Clinical aspects of cardiomyopathy in dialysis patients. Blood Purif (1994) 0.75
More on the treatment of end-stage renal disease. N Engl J Med (1991) 0.75
Telemedicine and fetal ultrasonography in a remote Newfoundland community. CMAJ (2000) 0.75
Investigation and management of renal stones. Can Fam Physician (1989) 0.75
Renal transplantation in primary hyperoxaluria/oxalosis: a report of two cases. Transplant Proc (1987) 0.75
Clinical and echocardiographic heart disease in renal transplant patients: prevalence and risk factors. Transplant Proc (1987) 0.75
Procainamide acetylation and disposition in dialysis patients. Clin Invest Med (1979) 0.75
Heart failure and ischemic heart disease in chronic uremia. Curr Opin Nephrol Hypertens (1995) 0.75
The relationship between hypertension and left ventricular hypertrophy in renal transplant recipients. Transplant Proc (1988) 0.75
Long-term cardiac morbidity and mortality during dialysis therapy. Adv Nephrol Necker Hosp (1994) 0.75
The management of cardiac disease in chronic uremia. Curr Opin Nephrol Hypertens (1994) 0.75